Saltar al contenido
Merck
Todas las fotos(2)

Documentos

GF90139417

Thulium

foil, not light tested, 12.5x12.5mm, thickness 0.002mm, as rolled, 99%

Sinónimos:

Thulium, TM000205

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(2)

About This Item

Fórmula empírica (notación de Hill):
Tm
Número de CAS:
7440-30-4
Peso molecular:
168.93
MDL number:
MFCD00011281
UNSPSC Code:
12141615
PubChem Substance ID:
329813572
NACRES:
NA.23

assay

≥99%

form

foil

manufacturer/tradename

Goodfellow 901-394-17

resistivity

90 μΩ-cm, 20°C

bp

1950 °C (lit.)

mp

1545 °C (lit.)

density

9.332 g/mL at 25 °C (lit.)

SMILES string

[Tm]

InChI

1S/Tm

InChI key

FRNOGLGSGLTDKL-UHFFFAOYSA-N

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Storage Class

13 - Non Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Kun Tang et al.
Journal of endourology, 28(1), 65-72 (2013-08-29)
To assess the efficacy and safety of thulium laser resection of the prostate (TmLRP) vs transurethral resection of the prostate (TURP) for treating patients with benign prostatic hyperplasia (BPH). A systematic search of the electronic databases, including Medline, Scopus, China
Amedeo Calisto et al.
Journal of neurosurgery. Pediatrics, 14(6), 563-572 (2014-10-18)
Hypothalamic hamartomas (HH) may induce drug-resistant epilepsy (DRE), thereby requiring surgical treatment. Conventionally, treatment is aimed at removing the lesion, but a disconnection procedure has been shown to be safer and at least as effective. The thulium laser (Revolix) has
T Bach et al.
World journal of urology, 28(2), 163-168 (2010-03-06)
Tm:YAG 2 mum cw laser prostatectomy was introduced in the treatment of benign ptostatic obstruction (BPO). Since then numerous studies have been published proving efficacy during follow-up. However, different surgical techniques were introduced with different names for similar techniques that
Li Li et al.
Journal of nanoscience and nanotechnology, 14(6), 4313-4319 (2014-04-18)
Lutetium oxide nanocrystals codoped with Tm3+ and Yb3+ have been successfully synthesized via adjusting the pH values of the precursor solution in a hydrothermal method followed by a subsequent calcination process. The samples were systematically characterized by X-ray diffraction, field-emission
Giovanni Muto et al.
Urology, 83(4), 851-855 (2014-02-20)
To determine whether thulium:yttrium-aluminum-garnet laser resection of bladder tumor (TmLRBT) may offer advantages over classic resection. From April 2011 to September 2012, 55 consecutive patients newly diagnosed with clinical stage ≤T2 bladder cancer were enrolled in a prospective study on TmLRBT.
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico